CordLife has opened its operation in Kolkata, India with state- of- the- art cord blood tissue processing and storage facility. The facility received an official license from the central and state drug regulatory authorities, a department within the Ministry of Health and Family Welfare of India.

CordLife  a leading cord blood banking company headquartered in Singapore owns a majority stake in this newly opened operation while the rest lies with Strassenburg Pharmaceuticals, a Kolkata based business group having interests in metal packaging materials, glass containers and PET bottles and one of the leading pharmaceuticals company in the eastern India. It is the first majority foreign owned cord blood bank in India and fifth facility added to CordLife’s extensive network of facilities in Singapore, Hong Kong, Indonesia and Australia.

The facility is build on 19,000 sq ft of land situated in the outskirts of Kolkata with storage capacity of more than 40,000 cord blood units scalable up to 150,000 units.

Mr Steven Fang, Group CEO, CordLife said that the facility was built with strict standards drawn from the group’s experience which has achieved international quality marks and accreditations such as AABB, TGA, Ministry of Health Singapore, and ISO 9001:2000. Mr Meghnath Roy Chowdhury, managing director, CordLife Sciences India said that cord blood banking as an industry has tremendous scope in India.